Abstract
The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Current Pharmaceutical Biotechnology
Title: Molecular Recognition Mechanisms for Detecting Cell Death In Vivo
Volume: 11 Issue: 6
Author(s): Ming Zhao
Affiliation:
Keywords: Apoptosis, Necrosis, Imaging, Probe
Abstract: The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Export Options
About this article
Cite this article as:
Zhao Ming, Molecular Recognition Mechanisms for Detecting Cell Death In Vivo, Current Pharmaceutical Biotechnology 2010; 11 (6) . https://dx.doi.org/10.2174/138920110792246591
DOI https://dx.doi.org/10.2174/138920110792246591 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued) VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data
Current Bioinformatics What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors
Central Nervous System Agents in Medicinal Chemistry Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
Reviews on Recent Clinical Trials Innovative Strategies in In Vivo Apoptosis Imaging
Current Medicinal Chemistry Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer
Current Drug Targets Targeting the BRCA1/2 Tumor Suppressors
Current Drug Targets Toxicogenomics to Evaluate Endocrine Disrupting Effects of Environmental Chemicals Using the Zebrafish Model
Current Genomics Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy
Current Cancer Therapy Reviews A Case Series of Malign Hyperechoic Breast Lesions
Current Medical Imaging Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment
Current Cancer Drug Targets Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach
Anti-Cancer Agents in Medicinal Chemistry New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias
Current Cancer Drug Targets Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy
Current Medicinal Chemistry Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters New Framework for the Discovery of PRC2 Inhibitors: Epigenetic Drugs
Current Drug Targets